• head_banner_01

China Manufacturer for Budesonide - Teriparatide Acetate API for Osteoporosis CAS NO.52232-67-4 – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We'll make every effort and hard work being outstanding and excellent, and speed up our techniques for standing during the rank of global top-grade and high-tech enterprises for Suxamethonium Chloride, Calais, Lithium Bromide Structure, We honor our core principal of Honesty in business, priority in service and will do our best to offer our customers with high quality products and excellent service.
China Manufacturer for Budesonide - Teriparatide Acetate API for Osteoporosis CAS NO.52232-67-4 – Gentolex Detail:

Product Detail

Name  Teriparatide Acetate
Cas No.  52232-67-4Molecular
Formula  C181h291n55o51s2
Appearance  white to off white
Delivery Time  Ready in Stock
Package  Aluminum Foil Bag
Purity  ≥98%
Storage 2-8 degree
Transportation  Cold chain and cool storage delivery

Synonyms

PARATHYROIDHORMONEHUMAN: FRAGMENT1-34; PARATHYROIDHORMONE(HUMAN,1-34); PARATHYROIDHORMONE (1-34), HUMAN; PTH (1-34) (HUMAN); PTH(HUMAN,1-34); TERIPARATIDE; Teriparatide acetate. 

Function

Teriparatide can mediate bone metabolism by inhibiting osteoblast apoptosis, activating bone lining cells, and enhancing osteoblast differentiation. Intermittently stimulates the PHT-I receptor on the surface of osteoblasts, bone lining cells and bone marrow stromal stem cells by regulating the adenylate cyclase-cyclic adenosine monophosphate-protein kinase A pathway to promote osteoblast differentiation and prolong osteogenesis cell lifespan; Stimulates the proliferation of osteoblast cell lines through the phosphate C-cytoplasmic calcium-protein Chemicalbook kinase C signaling pathway; By inhibiting the transactivation activity of PPARγ, it reduces the differentiation of stromal cells to adipocyte lineage and increases the number of osteoblasts; Indirectly regulate bone growth by regulating cytokines, for example, iGF-1 can be induced to bind to osteoblasts, thereby promoting bone formation;

The process of bone formation is regulated by the Wnt signaling pathway, thereby increasing bone formation.

FAQ

Can you supply the relevant documentation?

Yes, we can provide most documentation including Certificates of Analysis / Conformance; Insurance; Origin, and other export documents where required.

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

China Manufacturer for Budesonide - Teriparatide Acetate API for Osteoporosis CAS NO.52232-67-4 – Gentolex detail pictures

China Manufacturer for Budesonide - Teriparatide Acetate API for Osteoporosis CAS NO.52232-67-4 – Gentolex detail pictures


Related Product Guide:

With our loaded working experience and thoughtful products and services, we've got been acknowledged as a reputable supplier for most international buyers for China Manufacturer for Budesonide - Teriparatide Acetate API for Osteoporosis CAS NO.52232-67-4 – Gentolex , The product will supply to all over the world, such as: Maldives, Kyrgyzstan, Swaziland, To make every client satisfied with us and achieve win-win success, we will continue to try our best to serve and satisfy you! Sincerely looking forward to cooperating with more overseas customers based on mutual benefits and great future business. Thank you.
  • Goods just received, we are very satisfied, a very good supplier, hope to make persistent efforts to do better.
    5 Stars By Kitty from Johor - 2017.02.18 15:54
    A good manufacturers, we have cooperated twice, good quality and good service attitude.
    5 Stars By Janice from Greenland - 2017.08.15 12:36
    Write your message here and send it to us